New partnership may pave the way for first Novo Nordisk stem cell treatment
The new partnership with Japanese company Heartseed may give Novo Nordisk the chance to launch a stem cell therapy earlier than expected.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT
Novo Nordisk is expanding its interest in stem cells to a new disease area through the new agreement with Heartseed.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
